Research on the Reasons and the Related Measures for the High Price of Anticancer Drugs in China

Dai Guolin, Basang Jiba, Ma Shuang

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (8) : 956-961.

Chinese Pharmaceutical Affairs ›› 2020, Vol. 34 ›› Issue (8) : 956-961. DOI: 10.16153/j.1002-7777.2020.08.015
Pharmacoeconomics

Research on the Reasons and the Related Measures for the High Price of Anticancer Drugs in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2020, 34(8): 956-961 https://doi.org/10.16153/j.1002-7777.2020.08.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉